Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Poolbeg Pharma (POLB) Regulatory News

Date Source Headline
12th Dec 2022 12:00 pm EQS Poolbeg Pharma receives initial results from human challenge clinical study
12th Dec 2022 7:00 am RNS POLB 001 LPS human challenge trial completed
29th Nov 2022 7:00 am RNS Influenza AI model build completed
21st Nov 2022 11:37 am EQS Poolbeg Pharma wins first non-dilutive grant funding
18th Nov 2022 2:00 pm RNS Price Monitoring Extension
17th Nov 2022 2:05 pm RNS Second Price Monitoring Extn
17th Nov 2022 2:00 pm RNS Price Monitoring Extension
17th Nov 2022 7:00 am RNS Capital Markets Day
15th Nov 2022 10:36 am RNS Poolbeg-led consortium awarded EUR 2.3m grant
9th Nov 2022 1:53 pm EQS Poolbeg Pharma makes virus 'breakthrough' using AI drug discovery technology
8th Nov 2022 7:00 am RNS AI programme yields novel RSV drug targets
21st Oct 2022 7:00 am RNS Upcoming events participation
6th Oct 2022 4:40 pm RNS Second Price Monitoring Extn
6th Oct 2022 4:35 pm RNS Price Monitoring Extension
6th Oct 2022 7:00 am RNS CEO Share Purchase
4th Oct 2022 7:00 am RNS POLB 001 US Patent update
21st Sep 2022 7:00 am RNS Poolbeg licence of Melioidosis vaccine candidate
12th Sep 2022 7:00 am RNS HC Wainwright Global Investment Conference
6th Sep 2022 2:05 pm RNS Second Price Monitoring Extn
6th Sep 2022 2:00 pm RNS Price Monitoring Extension
6th Sep 2022 7:00 am RNS Interim Results
31st Aug 2022 7:25 am RNS Notice of Results
29th Jul 2022 7:00 am RNS Appointment of Joint Broker
20th Jul 2022 7:00 am RNS POLB001 human challenge clinical trial to commence
12th Jul 2022 2:06 pm RNS Second Price Monitoring Extn
12th Jul 2022 2:00 pm RNS Price Monitoring Extension
27th Jun 2022 7:00 am RNS Project update for AI model of RSV data
21st Jun 2022 4:40 pm RNS Second Price Monitoring Extn
21st Jun 2022 4:36 pm RNS Price Monitoring Extension
26th May 2022 2:05 pm RNS Second Price Monitoring Extn
26th May 2022 2:00 pm RNS Price Monitoring Extension
26th May 2022 7:00 am RNS US patents granted for POLB 001 and POLB 002
25th May 2022 4:40 pm RNS Second Price Monitoring Extn
25th May 2022 4:35 pm RNS Price Monitoring Extension
23rd May 2022 1:01 pm RNS TR-1: Notification of major interest in shares
12th May 2022 7:00 am RNS GMP manufacturing contract signed
11th May 2022 7:00 am RNS Attendance at European Melioidosis Congress
27th Apr 2022 7:00 am RNS Distribution in Specie update
14th Apr 2022 7:00 am RNS Key POLB 002 European Patent Granted
11th Apr 2022 7:00 am RNS Distribution in Specie Shareholders
FTSE 100 Latest
Value10,223.54
Change51.78